« As Last Ditch Effort KV Pharma Sues FDA Over Makena | Main | Biotech Funding Blues »

07/11/2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01774340dbbf970d

Listed below are links to weblogs that reference Amicus Briefs in Myriad Examined:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

patent litigation

I applaud the U.S. for acknowledging (albeit indirectly) in its amicus brief that the most significant issues regarding gene patents revolve around policy, rather than hard science. In my opinion, any decision as to whether to permit such patents can only be satisfactorily resolved by considering their effects on society at large.
http://www.aminn.org/patent-legislation

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada